Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
US6410747B1 · kind B1 · utility
13Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 1999 |
| Grant date | Jun 25, 2002 |
| Priority date | — |
| Expiry date | Jun 17, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for preventing or treating cognitive impairments associated with aging or Alzheimer's disease which comprises treating a patient at risk for having the cognitive impairment with an effective amount of a highly selective butyrylcholinesterase inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.